» Articles » PMID: 31401830

Detection of Anti- Antibodies in Human Sera Using Synthetic Glycosylphosphatidylinositol Glycans on a Bead-Based Multiplex Assay

Overview
Journal Anal Chem
Specialty Chemistry
Date 2019 Aug 13
PMID 31401830
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Toxoplasmosis, while often an asymptomatic parasitic disease in healthy individuals, can cause severe complications in immunocompromised persons and during pregnancy. The most common method to diagnose infections is the serological determination of antibodies directed against parasite protein antigens. Here we report the use of a bead-based multiplex assay containing a synthetic phosphoglycan portion of the glycosylphosphatidylinositol (GPI) for the detection of GPI-specific antibodies in human sera. The glycan was conjugated to beads at the lipid site to retain its natural orientation and its immunogenic groups. We compared the response against GPI with that against the protein antigen SAG1, a common component of commercial serological assays, via the detection of parasite-specific human IgG and IgM antibodies, respectively. The GPI-based test is in excellent agreement with the results for the commercial ELISA, as the ROC analysis of the GPI test shows 97% specificity and 98% sensitivity for the assay. GPI was a more reliable predictor for a parasite-specific IgM response compared to SAG1, indicating that a bead-based multiplex assay using GPI in combination with SAG1 may strengthen serology, in particular in seroepidemiological studies.

Citing Articles

Serum Testosterone-Estradiol Ratio in Toxoplasma-Seropositive Infertile Men: A Prospective, Single-Center Study.

Ragab A, Hamdy D, Ibrahim S J Reprod Infertil. 2024; 25(1):28-37.

PMID: 39157278 PMC: 11330197. DOI: 10.18502/jri.v25i1.15196.


A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity.

Stern D, Meyer T, Treindl F, Mages H, Kruger M, Skiba M Sci Rep. 2023; 13(1):21846.

PMID: 38071261 PMC: 10710470. DOI: 10.1038/s41598-023-48581-9.


Advances and Challenges in Diagnostics of Toxoplasmosis in HIV-Infected Patients.

Wesolowski R, Pawlowska M, Smogula M, Szewczyk-Golec K Pathogens. 2023; 12(1).

PMID: 36678458 PMC: 9862295. DOI: 10.3390/pathogens12010110.


Expression of in vivo biotinylated recombinant antigens SAG1 and SAG2A from Toxoplasma gondii for improved seroepidemiological bead-based multiplex assays.

Klein S, Stern D, Seeber F BMC Biotechnol. 2020; 20(1):53.

PMID: 33023547 PMC: 7542104. DOI: 10.1186/s12896-020-00646-7.


Recent progress in chemical synthesis of bacterial surface glycans.

Li R, Yu H, Chen X Curr Opin Chem Biol. 2020; 58:121-136.

PMID: 32920523 PMC: 7880230. DOI: 10.1016/j.cbpa.2020.08.003.


References
1.
Robert-Gangneux F, Meroni V, Dupont D, Botterel F, Garcia J, Brenier-Pinchart M . Toxoplasmosis in Transplant Recipients, Europe, 2010-2014. Emerg Infect Dis. 2018; 24(8):1497-1504. PMC: 6056100. DOI: 10.3201/eid2408.180045. View

2.
Liu Q, Wang Z, Huang S, Zhu X . Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015; 8:292. PMC: 4451882. DOI: 10.1186/s13071-015-0902-6. View

3.
Azzouz N, Shams-Eldin H, Niehus S, Debierre-Grockiego F, Bieker U, Schmidt J . Toxoplasma gondii grown in human cells uses GalNAc-containing glycosylphosphatidylinositol precursors to anchor surface antigens while the immunogenic Glc-GalNAc-containing precursors remain free at the parasite cell surface. Int J Biochem Cell Biol. 2006; 38(11):1914-25. DOI: 10.1016/j.biocel.2006.05.006. View

4.
Zhang K, Lin G, Han Y, Li J . Serological diagnosis of toxoplasmosis and standardization. Clin Chim Acta. 2016; 461:83-9. DOI: 10.1016/j.cca.2016.07.018. View

5.
Pomares C, Montoya J . Laboratory Diagnosis of Congenital Toxoplasmosis. J Clin Microbiol. 2016; 54(10):2448-54. PMC: 5035424. DOI: 10.1128/JCM.00487-16. View